35 years of innovation, care excellence and global expansion

Holger Crafoord and Nils Alwall in front of the first Gambro kidney (Photo belongs to Lund University, Sweden)

Our Swedish heritage goes back to professor Nils Alwall (1904-1986), nephrology chair at Lund University, and one of the founding fathers of dialysis. Nils collaborated with Swedish businessman Holger Crafoord to found Gambro, Inc. Over the past 35 years, Diaverum has become a global leader and the largest independent renal service provider in Europe.

1991

Gambro opens its first dialysis clinic in Sweden, Lund.

2007

Gambro Healthcare clinics continued to expand globally and, by the end of 2007, operated 170 clinics in 14 countries, treating more than 14,000 patients. Driven by a new vision, the name Diaverum was adopted and launched worldwide.

2011

Diaverum enters Saudi Arabia in a joint venture with Nazer Group and initially establishes one greenfield clinic in Dammam. Diaverum enters Chile with the acquisition of four clinics. Diaverum enters Romania and adds nine clinics across the country.

2013

Diaverum Germany expands, adding four new clinics in Hamburg, one of them being one of the largest dialysis clinics in Europe.

2014

Diaverum wins 50% of outsourced dialysis services contract with Ministry of Health Saudi Arabia to care for more than 5,000 patients. Diaverum enters Russia by acquiring ten clinics of Unona, mainly located in the Sverdlovsk region.

2015

Diaverum enters the Asian market through its acquisition of Nefros Asia in Kazakhstan with nine kidney centres across the country.

2016

Diaverum acquires International Healthcare Systems (IHS) in Romania and adds 15 new clinics to the network.

2018

Diaverum opens state of the art transplant center d.INSTITUTE ITAC for complex transplants in Argentina. Diaverum enters Brazil and North Macedonia.

2019

Diaverum enters Albania, and enters Morocco through a partnership with Centre d’Hémodialyse de Marrakech, expanding Diaverum’s presence to 22 countries worldwide. Diaverum strengthens its presence in the Middle East with renewal of its five-year dialysis contract in Saudi Arabia. Diaverum serves more than 39,000 patients in more than 400 clinics across the globe excluding the US.